Aberrant DNA Double-strand Break Repair Threads in Breast Carcinoma: Orchestrating Genomic Insult Survival-Reference-Cited by-同舟云学术

Aberrant DNA Double-strand Break Repair Threads in Breast Carcinoma: Orchestrating Genomic Insult Survival

Published:2016-12-30 Issue:4 Volume:21 Page:227-234
ISSN:2288-3649
Container-title:Journal of Cancer Prevention
language:en
Short-container-title:J Cancer Prev

Author:

Kumar Azad¹,Purohit Shruti¹,Sharma Nilesh Kumar¹

Affiliation:

1. Cancer and Translational Research Lab, Dr. D. Y. Patil Biotechnology & Bioinformatics Institute, Dr. D. Y. Patil Vidyapeeth, Pune, Maharashtra, India

Publisher

Korean Society of Cancer Prevention

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

http://pdf.medrang.co.kr/Jkacp2/021/Jkacp021-04-03.pdf

Reference76 articles.

1. Triple negative breast cancer cell lines: One tool in the search for better treatment of triple negative breast cancer

2. Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer

3. DNA methylation and hormone receptor status in breast cancer

4. DNA Damage in Cancer Therapeutics: A Boon or a Curse?

5. Targeting the DNA Damage Response in Cancer

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Facets of DNA Double Strand Break Repair: Radiation Dose as Key Determinant of HR versus c-NHEJ Engagement;International Journal of Molecular Sciences;2023-10-06

2. Advances in the role of long non‑coding RNAs and RNA‑binding proteins in regulating DNA damage repair in cancer cells;International Journal of Molecular Medicine;2023-08-23

3. DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy;Signal Transduction and Targeted Therapy;2021-07-09

4. Molecular avenues in targeted doxorubicin cancer therapy;Future Oncology;2020-04

5. RAD52 as a Potential Target for Synthetic Lethality-Based Anticancer Therapies;Cancers;2019-10-14